Total revenue increased 54% to $32.6 million in 2025 from $21.1 million in 2024. Gross profit improved significantly to $5.3 million (16% of sales) in 2025 from a loss of $(0.1) million (-1% of sales) in 2024. Operating income was $0.4 million in 2025, a substantial improvement from an operating loss of $4.4 million in 2024. Net income for 2025 was $0.4 million ($0.03 per basic share), reversing a net loss of $3.1 million ($0.22 per basic share) in 2024. Cash and cash equivalents increased to $4.5 million at year-end 2025 from $3.3 million in 2024, partly due to an equity raise. An equity raise on October 8, 2025, generated net proceeds of $9.54 million from the sale of 3,450,000 shares at $3.00 per share. The company's backlog stood at $26 million as of December 27, 2025, mostly scheduled for shipment in 2026. Three largest customers accounted for 64% of revenue in 2025 (39%, 13%, and 12% individually), up from 58% in 2024. Approximately 81% of 2025 revenues were derived from commercial applications and 19% from defense-related applications. The company is actively pursuing a move to a larger facility to support anticipated growth. The "One Big Beautiful Bill Act" signed on July 4, 2025, will impact future tax positions, including immediate expensing for R&E expenditures.